According to the findings of a study published in the journal 'Circulation: Genomic and Precision Medicine', an entirely new field of tailored medicines for patients at risk of coronary heart disease could be determined from their genes.
Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal consequence caused by monoclonal antibodies, which are used to treat a variety of tumours.
Clinicians have traditionally treated cardiovascular disease by focusing on diabetes and blood pressure control, as well as lowering cholesterol with drugs such as aspirin and statins.
According to the findings of six-month research headed by Johns Hopkins Medicine researchers, using portable home air purifiers can improve some markers of cardiovascular health in adults with chronic obstructive pulmonary disease or COPD.